Stemline Therapeutics

Home » Stemline Therapeutics

Secondary

Stemline Therapeutics

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics.

Symbol

STML

Last Closing Price
$14.15

Shares
3,700,000

Effective Date
January 24, 2018

Underwriters
J.P. Morgan, Cowen & Co.

To view the prospectus for Stemline Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253